Telithromycin- and Fluoroquinolone-Resistant Streptococcus pneumoniae in Taiwan with High Prevalence of Resistance to Macrolides and β-Lactams: SMART Program 2001 Data
Open Access
- 1 July 2003
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 47 (7) , 2145-2151
- https://doi.org/10.1128/aac.47.7.2145-2151.2003
Abstract
There is a high prevalence of β-lactam- and macrolide-resistant Streptococcus pneumoniae in Taiwan. To understand the in vitro susceptibilities of recent isolates of S. pneumoniae to fluoroquinolones and telithromycin (which is not available in Taiwan), the MICs of 23 antimicrobial agents for 936 clinical isolates of S. pneumoniae isolated from different parts of Taiwan from 2000 to 2001 were determined by the agar dilution method. Overall, 72% of isolates were not susceptible to penicillin (with 61% being intermediate and 11% being resistant) and 92% were resistant to erythromycin. Telithromycin MICs were ≥1 μg/ml for 16% of the isolates, and for 99% of these isolates the MICs of all macrolides tested were ≥256 μg/ml; all of these isolates had the constitutive macrolide-lincosamide-streptogramin B phenotype. Eighty-eight percent of the isolates were resistant to three or more classes of drugs. The ciprofloxacin MICs were ≥4 μg/ml for six (0.6%) isolates from five patients collected in 2000 and 2001, and the levofloxacin MICs were ≥8 μg/ml for five of these isolates. Seven isolates for which ciprofloxacin MICs were ≥4 μg/ml, including one isolate recovered in 1999, belonged to three serotypes (serotype 19F, five isolates; serotype 23A, one isolate; and serotype 23B, one isolate). The isolates from the six patients for which ciprofloxacin MICs were ≥4 μg/ml had different pulsed-field gel electrophoresis profiles and random amplified polymorphic DNA patterns, indicating that no clonal dissemination occurred over this time period. Despite the increased rate of fluoroquinolone use, the proportion of pneumococcal isolates for which ciprofloxacin MICs were elevated (≥4 μg/ml) remained low. However, the occurrence of telithromycin resistance is impressive and raises concerns for the future.Keywords
This publication has 35 references indexed in Scilit:
- Increased Prevalence of Erythromycin Resistance in Streptococci: Substantial Upsurge in Erythromycin-Resistant M Phenotype inStreptococcus pyogenes(1979-1998) but Not inStreptococcus pneumoniae(1985-1999) in TaiwanMicrobial Drug Resistance, 2002
- The responsibility of the pharmaceutical industryClinical Microbiology & Infection, 2001
- Fluoroquinolone Resistance amongStreptococcus pneumoniaein Hong Kong Linked to the Spanish 23F CloneEmerging Infectious Diseases, 2001
- In Vitro Activity of Telithromycin against Spanish Streptococcus pneumoniae Isolates with Characterized Macrolide Resistance MechanismsAntimicrobial Agents and Chemotherapy, 2001
- Trends in Ciprofloxacin Nonsusceptibility and Levofloxacin Resistance among Streptococcus pneumoniae Isolates in North America Journal of Clinical Microbiology, 2001
- In Vitro Activities of the Novel Ketolide Telithromycin (HMR 3647) against Erythromycin-Resistant Streptococcus SpeciesAntimicrobial Agents and Chemotherapy, 2001
- Novel Penicillin-, Cephalosporin-, and Macrolide-Resistant Clones of Streptococcus pneumoniae Serotypes 23F and 19F in Taiwan Which Differ from International Epidemic ClonesJournal of Clinical Microbiology, 2001
- Practice Guidelines for the Management of Community-Acquired Pneumonia in AdultsClinical Infectious Diseases, 2000
- Fluoroquinolone Resistance inStreptococcus pneumoniaeNew England Journal of Medicine, 1999
- The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada—1997 results from the SENTRY Antimicrobial Surveillance ProgramDiagnostic Microbiology and Infectious Disease, 1998